menu

Quintiles Library

Show Filters
Press Release
RESEARCH TRIANGLE PARK, N.C. – May 7, 2007 – Quintiles Transnational Corp. today announced the formation of a global biologics regulatory team to advise customers about development plans and optimal strategy for regulatory submissions for vaccines, monoclonal antibodies, stem-cell based therapies and other biological products. The team has been created in response to...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – April 6, 2007 – Dennis Gillings, CBE, Chairman and CEO of Quintiles Transnational Corp., today dedicated the company’s new central lab in Mumbai, India, and congratulated Quintiles India for its 10 years of growth and leadership in clinical research. The new lab expands Quintiles’ global central laboratory network and enhances the suite of...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – Feb. 13, 2007 – Dennis Gillings, CBE, Chairman and CEO of Quintiles Transnational Corp., was joined yesterday in the formal opening of Quintiles’ new data processing facility in Williamston, N.C., by North Carolina Commerce Department Secretary Jim Fain, together with N.C. Rep. Edith Warren; Tommy Bowen, Chairman of the Martin County Board...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – January 8, 2007 – NovaQuest, the strategic partnering group of Quintiles Transnational Corp., continues to be a leader in providing funding, strategic expertise and management services to emerging biotechnology companies worldwide, forming 16 such alliances through its investments in 2006. NovaQuest participated as a minority investor in...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – November 6, 2006 – Quintiles Transnational Corp. today announced that Paula Brown Stafford, Executive Vice President, Global Data Management, has been elected to the Board of Directors of CDISC, an industry consortium that leads the development of data standards to improve medical research. CDISC, the Clinical Data Interchange Standards...
Read More
Press Release
BRUSSELS, BELGIUM and RESEARCH TRIANGLE PARK, N.C. – October 24, 2006 – Solvay Pharmaceuticals has renewed for another five years its clinical development strategic alliance with Quintiles, first signed in 2001, Solvay Pharmaceuticals and Quintiles Transnational Corp. announced today. The renewal reflects the alliance's success in accelerating development of Solvay's...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – October 16, 2006 – Quintiles Transnational Corp. today announced plans to open a central lab in Mumbai, India, further expanding the company’s global network of labs that support global and regional clinical trials.The new lab, owned and operated by Quintiles, will be equipped and staffed before the end of 2006 and is expected to be ready to...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – October 2, 2006 – Quintiles Transnational Corp. today announced that John Ratliff has been appointed as its new Chief Operating Officer, effective immediately. He will be responsible for directing Quintiles’ daily global operations and will report to Chairman and Chief Executive Officer, Dennis Gillings, CBE. Ratliff also has been elected to...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – August 8, 2006 – Quintiles Transnational Corp. today announced the expansion of its global data management network with the opening of a clinical data processing center in Williamston, N.C. The center will provide up to 70 new jobs in the eastern region of the state and build additional capacity for customers seeking services provided by...
Read More
Press Release
August 1, 2006 – Steven M. Niedelman, formerly deputy associate commissioner for Regulatory Operations for the U.S. Food and Drug Administration, has joined Quintiles Consulting as executive vice president, Quintiles Transnational Corp. announced today. Niedelman, whose 34-year FDA career culminated with responsibility for approximately one-third of all FDA staff, is...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – July 24, 2006 – Quintiles Transnational Corp. today announced the creation of the Strategic Biostatistics Unit to help customers cut the time and reduce the costs of drug development through the "adaptive design" of clinical trials and other innovative statistical approaches. A study design is called "adaptive" if it allows modification of...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – June 6, 2006 – Quintiles Transnational Corp. today announced that its Quintiles East Asia subsidiary has been named the Asia Pacific region's Multinational Clinical Trials Service Provider of the Year and Multinational CRO of the Year by the consulting firm Frost & Sullivan. Frost & Sullivan presents the awards to companies that demonstrate...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – May 11, 2006 – Quintiles Transnational Corp. today announced the launch of its expanded strategic partnering group under the NovaQuest™ brand and, to further NovaQuest's mission, an alliance with TPG-Axon Capital, a global investment firm with over $5.8 billion in equity capital. NovaQuest helps life-science companies realize greater value...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 31, 2006 – Quintiles Transnational Corp. today announced that it has completed new credit facility arrangements. The new credit facilities include a $225 million first lien revolving credit facility due in 2012, a $1.0 billion first lien term loan due in 2013 and a $220 million second lien term loan due in 2014. Proceeds from the...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 29, 2006 – Quintiles Transnational Corp. today announced the appointment of Yoh Narimatsu as President and Chief Executive Officer of Quintiles Transnational Japan K.K. (Quintiles Japan) effective April 1.Narimatsu, who has more than 30 years of international business experience, will lead all operations of Quintiles Japan. Quintiles...
Read More
Press Release
WASHINGTON – March 21, 2006 – Quintiles Transnational Corp., the world's leading pharmaceutical services organization, today announced it has donated $100,000 to the Seattle Vaccine Research Fund (SVRF) to support anti- retroviral treatment for HIV vaccine trial participants who become infected during vaccine studies.The recently formed Seattle Vaccine Research Fund was...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 20, 2006 – Quintiles Transnational Corp. today announced that it has reached a significant milestone in data management – the 200th clinical trial using Electronic Data Capture (EDC). Quintiles is using EDC in a trial being conducted in the United Kingdom for Aerovance, Inc., of Berkeley, Calif., which is studying a drug candidate for...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 17, 2006 – Quintiles Transnational Corp. ("Quintiles") and Pharma Services Intermediate Holding Corp. ("Holding;" each of Holding and Quintiles, is referred to as a "Company") today announced that, in connection with the previously announced tender offer and consent solicitation for any and all of Quintiles' outstanding $450.0 million...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 3, 2006 – Quintiles Transnational Corp. today announced that it and Pharma Services Intermediate Holding Corp. ("Holding;" each of Holding and Quintiles, is referred to as a "Company") have commenced a cash tender offer for any and all of Quintiles' outstanding $450.0 million aggregate principal amount 10% senior subordinated notes due...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – January 20, 2006 – Quintiles Transnational Corp. today announced that its central laboratory operation in China has earned two significant certifications – one from the College of American Pathologists (CAP) and the other from the National Glycohemoglobin Standardization Program (NGSP). Quintiles provides central lab services in China...
Read More